|
GB699080A
(en)
|
1950-05-31 |
1953-10-28 |
Ici Ltd |
Production of new esters of ortho-phosphoric acid and salts thereof
|
|
US3930024A
(en)
|
1969-09-02 |
1975-12-30 |
Parke Davis & Co |
Pharmaceutical compositions and methods
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US5019383A
(en)
|
1981-01-09 |
1991-05-28 |
New York Blood Center, Inc. |
Fatty acid carriers for synthetic peptides
|
|
DE3127503A1
(de)
|
1981-07-11 |
1983-02-17 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Neue phospholipide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
|
US4464383A
(en)
|
1981-11-24 |
1984-08-07 |
Itaru Yamamoto |
Immunomodulator containing trithiazole pentamethine cyanine derivative
|
|
ZA831547B
(en)
|
1982-03-15 |
1984-10-31 |
New York Blood Center Inc |
Fatty acid carriers for synthetic vaccines
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
EP0122151B1
(en)
|
1983-04-11 |
1989-02-15 |
Meito Sangyo Kabushiki Kaisha |
Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
GR860379B
(en)
|
1985-02-22 |
1986-06-11 |
Akzo Nv |
Novel disaccharide and trisaccharide derivatives of the lipid a type
|
|
EP0219514A4
(en)
|
1985-04-03 |
1988-04-26 |
Wisconsin Alumni Res Found |
METHOD FOR PREVENTING DISEASES CAUSED BY GRAM-NEGATIVE ENDOTOXIN IN MAMMALY.
|
|
US5837249A
(en)
|
1985-04-19 |
1998-11-17 |
The Wistar Institute |
Method for generating an immunogenic T cell response protective against a virus
|
|
EP0203676B1
(en)
|
1985-04-19 |
1992-01-29 |
The Wistar Institute Of Anatomy And Biology |
Vaccine for generating an immunogenic t cell response protective against a virus
|
|
IT1213029B
(it)
|
1986-01-30 |
1989-12-07 |
Bracco Ind Chimica Spa |
Chelati di ioni metallici paramagnetici.
|
|
JPS63139186A
(ja)
|
1986-11-29 |
1988-06-10 |
Hidetoshi Tsuchida |
三本鎖型リン脂質化合物およびその製造方法
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US4868155A
(en)
|
1987-10-05 |
1989-09-19 |
Merck & Co., Inc. |
Dipeptidyl 4-0-,6-0-acyl-2-amino-2-deoxy-D-glucose compositions and methods of use in AIDS-immunocompromised human hosts
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
US5041427A
(en)
|
1989-07-21 |
1991-08-20 |
Wisconsin Alumni Research Foundation |
Lipid A derivatives
|
|
JPH0655749B2
(ja)
|
1989-09-20 |
1994-07-27 |
日本たばこ産業株式会社 |
リピッドａ単糖類縁体
|
|
FR2670787B1
(fr)
|
1990-12-18 |
1995-06-23 |
Pasteur Institut |
Lipopeptides inducteurs des lymphocytes t cytotoxiques et utilisation comme vaccins.
|
|
US5871746A
(en)
|
1990-12-18 |
1999-02-16 |
Institut National De La Sainte Et De La Recherche Medicale (Inserm) |
Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines
|
|
US5993823A
(en)
|
1990-12-18 |
1999-11-30 |
Institut Pasteur De Lille |
Cytotoxic T lymphocyte-inducing lipopeptides and methods of use
|
|
ES2044781B1
(es)
|
1992-04-14 |
1994-10-01 |
Menarini Lab |
Procedimiento para la preparacion de nuevas amidas con accion inhibidora de la fosfolipasa a2
|
|
US5580563A
(en)
|
1992-05-01 |
1996-12-03 |
Tam; James P. |
Multiple antigen peptide system having adjuvant properties, vaccines prepared therefrom and methods of use thereof
|
|
FR2702306B1
(fr)
|
1993-03-05 |
1995-04-14 |
Alcatel Nv |
Procédé d'auto-alignement d'un contact métallique sur un substrat de matériau semi-conducteur.
|
|
IT1264690B1
(it)
|
1993-07-08 |
1996-10-04 |
Bracco Spa |
Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi
|
|
US5744144A
(en)
|
1993-07-30 |
1998-04-28 |
University Of Pittsburgh University Patent Committee Policy And Procedures |
Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
|
|
DE4408248A1
(de)
|
1994-03-11 |
1995-09-14 |
Hoechst Ag |
Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung
|
|
WO1995027505A1
(en)
|
1994-04-12 |
1995-10-19 |
Biomira, Inc. |
Cellular immune response-specific antigens and uses therefor
|
|
WO1995029927A2
(en)
|
1994-05-02 |
1995-11-09 |
Biomira, Inc. |
Process for preparation of glycosides of tumor-associated carbohydrate antigens
|
|
WO1996040236A1
(en)
|
1995-06-07 |
1996-12-19 |
National Jewish Center For Immunology And Respiratory Medicine |
Isolated formylated bacterial peptides, nucleic acid molecules and uses thereof
|
|
AUPN568095A0
(en)
|
1995-09-27 |
1995-10-26 |
Austin Research Institute, The |
Anti-Galalpha(1,3)Gal antibody binding peptides
|
|
US5840839A
(en)
|
1996-02-09 |
1998-11-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
|
|
JP2001510440A
(ja)
|
1996-03-20 |
2001-07-31 |
スローン―ケタリング・インスティテュート・フォー・キャンサー・リサーチ |
ムチン接合体ペプチドワクチン
|
|
DE69730218D1
(de)
|
1996-04-11 |
2004-09-16 |
Univ British Columbia |
Fusogene liposomen
|
|
US5910306A
(en)
|
1996-11-14 |
1999-06-08 |
The United States Of America As Represented By The Secretary Of The Army |
Transdermal delivery system for antigen
|
|
ATE491465T1
(de)
|
1997-05-08 |
2011-01-15 |
Oncothyreon Inc |
Verfahren zur gewinnung aktivierter t-zellen und mit antigen-inkubierten antigen-präsentierender zellen
|
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
|
US6764840B2
(en)
|
1997-05-08 |
2004-07-20 |
Corixa Corporation |
Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
|
|
FR2774687B1
(fr)
|
1998-02-06 |
2002-03-22 |
Inst Nat Sante Rech Med |
Lipopeptides contenant un fragment de l'interferon gamma, et leur utilisation dans des compositions pharmaceutiques
|
|
CA2319688A1
(en)
*
|
1998-02-13 |
1999-08-19 |
Gunther Bastert |
Specific antibodies against mammary tumor-associated mucin, method for production and use
|
|
US6043390A
(en)
|
1998-04-03 |
2000-03-28 |
The Regents Of The University Of California |
Pentaerythritol lipid derivatives and nucleic-acid complexes
|
|
FR2776926B1
(fr)
|
1998-04-07 |
2003-10-24 |
Inst Nat Sante Rech Med |
Lipopeptides inducteurs de cytotoxicite t lymphocytaire portant au moins un epitope t auxiliaire, et leurs utilisations pour la vaccination
|
|
US20020051813A1
(en)
|
1999-01-15 |
2002-05-02 |
Lawrence Boni |
Lipomatrix preparation
|
|
US7147850B2
(en)
|
1999-08-18 |
2006-12-12 |
Altarex Medical Corp. |
Therapeutic binding agents against MUC-1 antigen and methods for their use
|
|
ES2239032T3
(es)
|
1999-08-18 |
2005-09-16 |
Altarex Medical Corp. |
Anticuerpo terapeutico contra el antigeno muc-1 y metodos para su uso.
|
|
PT1210430E
(pt)
|
1999-09-08 |
2006-12-29 |
Imp Cancer Res Tech |
Péptidos derivados de muc-1
|
|
ATE518874T1
(de)
|
1999-11-15 |
2011-08-15 |
Oncothyreon Inc |
Synthetische lipid-a analogen und verwendungen davon
|
|
US6699846B2
(en)
|
2000-03-17 |
2004-03-02 |
Corixa Corporation |
Mono- and disaccharides for the treatment of nitric oxide related disorders
|
|
EP1265632A2
(en)
|
2000-03-24 |
2002-12-18 |
Biomira, Inc. |
Lipopeptide adjuvants
|
|
ES2164013B1
(es)
|
2000-04-14 |
2003-06-16 |
Consejo Superior Investigacion |
Glicosidos de n-acetil-6-o-(2,2-bis(hidroximetil)-3-hidroxipropil)-d-glucosamina, procedimiento de obtencion y uso en el tratamiento de tumores cerebrales.
|
|
EP1182210A1
(en)
|
2000-08-17 |
2002-02-27 |
BASTERT, Gunter, Prof.Dr.med.Dr.h.c. |
Epitopes of tumor-associated MUC1 antigen
|
|
CA2421751C
(en)
*
|
2000-09-11 |
2014-02-11 |
Donald W. Kufe |
Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
|
|
EP1343476B1
(en)
|
2000-12-01 |
2008-05-28 |
Biomira Inc. |
Preparation of large liposomes by infusion into peg
|
|
CA2441809C
(en)
|
2001-03-27 |
2014-07-22 |
Biomira, Inc. |
Liposomal vaccines comprising dilipopeptides for modulating t1 and t2 immune responses
|
|
JP2005526497A
(ja)
|
2002-02-04 |
2005-09-08 |
ビオミラ，インコーポレーテッド |
免疫刺激性、共有結合性脂質化オリゴヌクレオチド
|
|
CA2482477A1
(en)
*
|
2002-04-15 |
2003-10-30 |
Biomira, Inc. |
Synthetic glyco-lipo-peptides as vaccines
|
|
DE60331330D1
(de)
|
2002-05-09 |
2010-04-01 |
Oncothyreon Inc |
Lipid-a- und andere kohlenhydrat-liganden-analoga
|
|
GB0212046D0
(en)
*
|
2002-05-24 |
2002-07-03 |
Glaxo Group Ltd |
Vaccines
|
|
US20030235610A1
(en)
|
2002-06-21 |
2003-12-25 |
Piedmont Pharmaceuticals, Llc |
Liposomes containing biologically active compounds
|
|
US9198645B2
(en)
|
2003-11-26 |
2015-12-01 |
The United States of America, as represented by the Secretary of Commerce of The National Institute of Standards and Technology |
Controlled vesicle self-assembly in continuous two phase flow microfluidic channels
|
|
TW201204410A
(en)
*
|
2004-04-01 |
2012-02-01 |
Oncothyreon Inc |
Mucinous glycoprotein (MUC-1) vaccine
|
|
AU2006274651B2
(en)
|
2005-06-28 |
2012-09-27 |
Oncothyreon Inc. |
Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
|
|
JP5126874B2
(ja)
|
2007-05-21 |
2013-01-23 |
国立大学法人神戸大学 |
リポソーム製剤の製造方法
|
|
SG172257A1
(en)
|
2008-12-17 |
2011-07-28 |
Oncothyreon Inc |
Method of making small liposomes
|